A phase I and pharmacologic study of 2-methoxyestradiol in patients with advanced solid tumors
Latest Information Update: 18 Sep 2021
At a glance
- Drugs 2-methoxyestradiol (Primary)
- Indications Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 16 Jan 2013 Biomarkers information updated
- 29 Sep 2005 New trial record.